Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma

Journal of Cutaneous Pathology

Volumn 33, Issue 7, 2006, Pages 492-497

  Arai, Eiichi ^a   Kuramochi, Akira ^a   Tsuchida, Tetsuya ^a   Tsuneyoshi, Masazumi ^b   Kage, Masayoshi ^c   Fukunaga, Masaharu ^d   Ito, Tomoo ^e   Tada, Toyohiro ^f   Izumi, Miki ^g   Shimizu, Ken ^h   Hirose, Takanori ^a   Shimizu, Michio ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^f NAGOYA CITY UNIVERSITY   (Japan)

^g TOKYO MEDICAL UNIVERSITY   (Japan)

^h Saitama Social Insurance Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; GLUCOSE TRANSPORTER 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2 40; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANGIOMA; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; SKIN TUMOR; TUFTED ANGIOMA; TUMOR DIFFERENTIATION; VASCULAR TUMOR;

ANTIBODIES, MONOCLONAL; CAPILLARIES; DIAGNOSIS, DIFFERENTIAL; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745898818     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00461.x     Document Type: Article

References (34)

1. Miettinen M. Diagnostic soft tissue pathology. Hong Kong: Churchill Livingston, 2003.
2. Weiss SW, Goldblum JR, eds. Enzinger and Weiss's soft tissue tumors, 4th edn. St Louis, MO: Mosby, 2001.
3. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangioma and vascular malformations. J Dermatol 1997; 24: 701.
4. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (New issues) Adv Dermatol 1997; 13: 375.
5. Requena I, Sangueza OP. Cutaneous vascular proliferations. II. Hyperplasia and benign neoplasms. J Am Acad Dermatol 1997; 37: 887.
6. Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr 1999; 11: 457.
7. Werner JA, Dunne AA, Folz BJ, et al. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2001; 258: 141.
8. Cooper JG, Edwards SL, Holmes JD. Kaposiform hemangioendothelioma: case report and review of the literature. Br J Plast Surg 2002; 55: 163.
9. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993; 17: 321.
10. Brasanac D, Janic D, Boricic I, et al. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int 2003; 53: 627.
11. Lyons LL, North P, Lai F, et al. Kaposiform hemangioendothelioma. A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004; 28: 559.
12. Fletcher CDM, Unni KK, Mertens F, eds. Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumors, Vol. 5. Lyon, France: IARC Press; 2002.
13. Vin-Christian K, McCalmont TH, Frieden IJ. Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol 1997; 133: 1573.
14. Beaubien ER, Ball NJ, Storwick GS. Kaposiform hemangioendothelioma: a locally aggressive vascular tumor. J Am Acad Dermatol 1998; 38: 799.
15. Mulliken JB, Anupindi S, Ezekowitz RAB, et al. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia-Kaposiform hemangioendothelioma with the Kasabach-Merritt phenomenon. N Engl J Med 2004; 350: 1764.
16. Cho KH. Tufted angioma: is it the same as angioblastoma (Nakagawa)? Arch Dermatol 1997; 133: 789.
17. Vanhooteghem O, Andre J, Bruderer P, et al. Tufted angioma, a particular form of angioma. Dermatology 1997; 194: 402.
18. Wong SN, Tay YK. Tufted angioma: a report of five cases. Pediatr Dermatol 2002; 19: 388.
19. Jones EW, Orkin M. Tufted angioma (angioblastoma): a benign progressive angioma, not to be confused with Kaposi's sarcoma or low-grade angiosarcoma. J Am Acad Dermatol 1989; 20: 214.
20. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002; 15: 434.
21. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. Br J Cancer 1999; 80: 569.
22. Tsang WYW, Chan JKC. Kaposi-like infantile hemangioendothelioma: a distinctive vascular neoplasm of the retroperitneum. Am J Surg Pathol 1991; 15: 982.
23. Calonje E, Wilson-Jones E. Vascular tumors. Tumors and tumor-like conditions of blood vessels and lymphatics. In: Elder DE, ed. Lever's Histopathology of the skin, 9th edn. Philadelphia: Lippincott, Willliams & Wilkins, 2005: 1015.
24. Mo JQ, Dimashkith HH, Bove AK. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004; 35: 200.
25. Chu AY, Litzky LA, Pasha TL, et al. Utility of D2, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005; 18: 105.
26. Schlingmann RO, Dingjan GM, Emeis J, et al. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 1985; 52: 71.
27. Fukunaga M. Expression of D2 in lymphatic endothelium of normal tissues and in vascular tumors. Histopathology 2005; 46: 396.
28. Mentzel T, Mazzoleni G, Deitos AP, et al. Kaposiform hemangioendothelioma in adults: clinicopathologic and immunohistochemical analysis of three cases. Am J Clin Pathol 1997; 108: 450.
29. Hsu CJ, Hsiao CH, Chiu HC. Kaposiform hemangioendothelioma. Dermatol Sin 2001; 19: 243.
30. Chu CY, Hsiano CH, Chiu HC. Transformation between kaposiform hemangioendothelioma and tufted angioma. Dermatology 2003; 206: 334.
31. Enjolras O, Mulliken JB, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000; 42: 225.
32. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have 'true' hemangiomas. J Pediatr 1997; 130: 631.
33. Sarkar M, Mulliken JB, Kozarkerwich HPW, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997; 100: 1377.
34. Michel S, Hohenleutner U, Stolz W, et al. Acquired tufted angioma in association with a complex cutaneous vascular malformation. Br J Dermatol 1999; 141: 1142.